Scientists at Northwestern and Case Western Reserve universities have developed the first polymer-based therapeutic for Huntington's disease, an incurable, debilitating illness that causes nerve cells ...

Engineered polymers interfere with protein interactions to protect cell health in a mouse study. Researchers at Northwestern University and Case Western Reserve University have developed the first ...

Scientists have developed a novel polymer-based therapy that could slow Huntington's disease progression by preventing ...

The new structure, resembling a polymer, protects peptides from degradation and facilitates their entry to cells.

Without functioning mitochondria, the cells become dysfunctional and then self-destruct. As part of that study, Qi also uncovered a naturally occurring peptide that disrupts the interaction between ...

A polymer has been developed to optimize the use of a peptide to treat Huntington’s disease in mice.

Studies support the idea of “polymers as therapeutics,” rather than polymers as carriers of drug molecules in the sense of ...

Without functioning mitochondria, the cells become dysfunctional and then self-destruct. The peptide faced several limitations. Since they are easily broken down by enzymes, peptides have a short ...

Researchers developed a polymer that delivers peptides to prevent toxic protein aggregation in Huntington’s disease. The ...